This high growth rate is attributed to factors such as
growing drug and alcohol consumption; government funding in major markets,
enforcement of stringent laws mandating drug and alcohol testing, and
regulatory approvals and new product and service launches
The report “Drug Screening Market by Product ((Immunoassay
Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug
Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace,
Criminal Justice, Hospital) – Global Forecast to 2027”, is expected to reach
USD 13.89 billion by 2027 from USD 5.32 billion in 2017, at a CAGR of 10.2%.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773
Services segment is expected to grow at the highest CAGR
during the forecast period.
Based on service and product, the drug screening market is
segmented into services and products. The services segment accounted for the
largest share of 57.4% of the drug
screening market in 2020. This segment is also expected to register the highest
CAGR during the forecast period, mainly due to the growing drug & alcohol
consumption worldwide, funding initiatives for drug testing laboratories,
service launches and regulatory approvals, and geographic expansion of drug
testing laboratories.
Analytical instruments are expected to dominate the drug
screening products market in 2020.
Based on the product, the drug screening market is segmented
into analytical instruments, rapid testing devices, and consumables. In 2020,
the analytical segment is expected to dominate the market with a share of
53.0%. The high growth in this segment is owing to their recurring requirement
and repetitive usage.
Browse and in-depth TOC on “Drug Screening Market”
204 – Tables
42 – Figures
203 – Pages
Based on the sample type, the urine sample segment is
accounted for the largest share of the drug screening market.
By sample type, drug screening market is segmented into
urine, breath, oral fluid, hair, and other samples. Among these, the urine
sample segment is expected to account for the largest share of 61.5% in 2020.
The high growth of this segment is attributed due to the benefits it offers
such as easy collection method, high accuracy in the detection of multiple
drugs, cost-effectiveness, and instant results.
North America to dominate the drug screening market in
2020.
In 2020, North America is expected to dominate the market
with a share of 48.2%, followed by Europe. The large share of this geographical
segment is attributed to factors such as growing consumption of illicit drugs,
the availability of government funding to curb drug abuse, laws supporting drug
screening, the growing burden of accidents due to alcohol impairment, and the
presence of key players in the region are driving the growth of the drug
screening market in this region.
The drug screening market is highly competitive with the
presence of several small and big players. Some of the players offering
products for drug screening market include Abbott Laboratories (US), Thermo
Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs (US),
Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and Shimadzu
(Japan).
What Drives the Market?
The growth of the global market for Drug Screening Market
is primarily influenced by the following factors:
1 Growing Drug & Alcohol Consumption
2 Enforcement of Stringent Laws Mandating Drug and Alcohol
Testing
3 Presence of Government Funding in Major Markets
4 Regulatory Approvals & Product Launches and Services
The objectives of this study are as follows:
1. To define, describe, segment, and forecast the global
market by product and service, sample type, end user, and region To provide
detailed information regarding the major factors influencing the growth of the
market (drivers, restraints, opportunities, challenges, and market-specific
trends)
2.To analyze micromarkets with respect to individual growth
trends, prospects, and contributions to the overall market
3. To analyze the opportunities in the market for
stakeholders and provide details of competitive landscape for market leaders
4. To forecast the size of the market segments with respect
to four main regions, namely, North America, Europe, Asia Pacific, and the Rest
of the World (RoW). To profile key players and comprehensively analyze their
market shares and core competencies
5. To track and analyze competitive developments such as
agreements, partnerships, and collaborations; acquisitions; product launches
and approvals; expansions; and R&D activities in the global market.
About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth emerging opportunities/threats which will impact 70% to 80%
of worldwide companies' revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their pain-points around revenues decisions.